NL-OMON23149已完成不适用
Microarray Analysis in breast cancer to Tailor Adjuvant Drugs Or Regimens, a randomized phase III study.
etherlands Cancer Institute-Antoni van Leeuwenhoek Hospital0 个研究点目标入组 660 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 660
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Women with pT1-T3, pN0-3b, M0 adenocarcinoma of the breast (TNM classification 2002). Women with a macrometastasis in the sentinel node, who did not receive an axillary dissection (pN1(sn)), are only eligible if radiotherapy of the axilla is included in the treatment plan (for instance experimental arm AMAROS study);
- •2. Known HER2 and estrogen receptor status;
排除标准
- •1. Prior systemic anticancer therapy for any cancer (immunotherapy, hormonal therapy, chemotherapy);
- •2. Prior radiation therapy for breast cancer;
研究者
相似试验
已完成
不适用
Microarray Analysis in breast cancer to Taylor Adjuvant Drugs Or Regimens, a randomized phase III studyBreastCancerBreast cancerISRCTN61893718etherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI AVL)664
已完成
不适用
Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural EffusionBreast NeoplasmsNeoplasm MetastasisGene Expression ProfilingImmunotherapyNCT01256801Peking University Cancer Hospital & Institute36
已完成
不适用
Molecular Analysis of Breast CancerBreast Cancer Non-invasive Breast CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Breast CancerNCT00569049Stanford University788
进行中（未招募）
不适用
Microarray Evaluaton of Normal Breast Tissue to Identify Genetic Markers of Risk for Estrogen Receptor Positive Breast CancerCancer - BreastInvasive Breast CancerACTRN12605000480684SSWAHS100
招募中
不适用
Breast Cancer Subtype Characterization Through Patient's Derived Organoids.OrganoidsBreast CancerNCT06315868Fondazione Policlinico Universitario Agostino Gemelli IRCCS306